Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
about
Interventions for improving health literacy in people with chronic kidney diseaseHemodialysis in AsiaHeme oxygenase-1 as a target for TGF-β in kidney diseaseHow to overcome barriers and establish a successful home HD programThe role of Th1 and Th17 cells in glomerulonephritis.International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data.Allocation of initial modality for renal replacement therapy in BrazilDesign and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patientsChronic kidney disease and support provided by home care services: a systematic reviewChronic kidney disease among high school students of Kinshasa.Renal replacement therapy in Ukraine: epidemiology and international comparisons.The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010.The EVEREST study: an international collaboration.Global trends in rates of peritoneal dialysisEarly chronic kidney disease: diagnosis, management and models of careType of Referral, Dialysis Start and Choice of Renal Replacement Therapy Modality in an International Integrated Care Setting.Chronic kidney disease in children: the global perspective.Exploring the association between macroeconomic indicators and dialysis mortality.Rehospitalizations and Emergency Department Visits after Hospital Discharge in Patients Receiving Maintenance HemodialysisReimbursement and economic factors influencing dialysis modality choice around the world.A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologistsChronic kidney disease in children.Forecasting the need for dialysis services in ontario, Canada to 2011.Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis.Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysisEconomic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis.Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.Underutilization of peritoneal dialysis: the role of the nephrologist's referral pattern.Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review.Challenges of providing maintenance hemodialysis in a resource poor country: Experience from a single teaching hospital in Lagos, Southwest Nigeria.Continually improving standards of care: The UK Renal Registry as a translational public health tool.Melamine induces human renal proximal tubular cell injury via transforming growth factor-β and oxidative stress.Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.Cardiac, Inflammatory and Metabolic Parameters: Hemodialysis versus Peritoneal Dialysis.Trends of cost and mortality of patients on haemodialysis with end stage renal disease.Interferon-γ Reduces the Proliferation of Primed Human Renal Tubular Cells.Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.Longitudinal analysis of market factors associated with provision of peritoneal dialysis services.
P2860
Q24186226-78316E67-066B-44F5-A392-E43443161246Q26740463-FFFB7B21-9F72-4528-8033-AF688A608664Q26998726-CD44E846-5FB1-40CF-AAC0-511B94A01A2BQ30415883-8D55AA19-F00C-416E-B8F8-EDD06834963BQ30487944-B62EC675-A45F-42A0-9A74-05E573FA35D6Q30940152-F5D4389D-8B52-401D-A95E-24BCB3731DCDQ33770016-DAD6A19A-4D20-41AD-92B2-EC93C9D71D2EQ33821580-3587249D-E2D1-40AA-8D52-FB20902E83C5Q34021739-B5E474D3-ACCF-4749-85C0-13C09D7D785CQ34257732-5BE228A6-25CF-4360-9218-2F5FB19EE0BDQ35227577-A4E9754E-5806-43D6-9AF6-E319F14F7B5CQ35452354-EA71CE65-B29A-490D-8BBD-EA3EAA123635Q35574292-E8F1E534-905B-48B8-BC17-954BD7D9861EQ35804211-24FC7DA8-A8F2-4415-AFA4-FBD5F218E3DFQ35938045-44CE4F44-0682-4583-9E2E-70D45C9BDB45Q36030639-872492A1-9998-41D8-A25B-A4BBB90047C1Q36120049-5D83F667-81C9-4EF2-A974-BAE2201224E3Q36294385-ED3CAD90-369E-4147-AF7A-D76C0C68BB2CQ36314897-D43B59E0-FAC3-4E3B-9A32-27349FF904FFQ36740044-E1CED673-BFA1-4E83-A6E7-16CC3EEE7242Q36831513-BCAC48DA-28B7-44F5-83FA-D5F3848DEA99Q37093409-1039A7CB-C819-43BE-B7CB-7D4AA99D7D3BQ37119068-1E3F5F73-0A3A-4C05-A57E-4F9444BAE312Q37238284-D7EA6B5E-5E62-49FF-9D57-8A1E96F241B8Q37356124-78DB4199-0B03-4706-ACA9-C91954E78489Q37389819-06C3AA8C-6041-44BB-838D-D3CAB644F189Q37582613-C2388BE9-3630-44DF-B60F-3F4D02507EFBQ37728210-4CB504BA-6B41-4724-9DE6-79BAB8A52229Q37959379-CF43E213-ED03-444F-B76F-FD22375CA034Q38050733-A773886B-DA53-472B-A337-FD1E9EABFC64Q38065884-B726D3FD-B0F5-4776-B466-394DE3122196Q38078488-1CCF2942-6287-479B-B99B-B56635DE3E68Q38712852-6CA567CE-29D3-4894-B5DB-BC6BB0521F55Q39292609-D4D6689D-FCD0-4ED6-B133-775E61B2114BQ40323097-AD4A766A-D255-4656-BCAA-60D02AA6C588Q41248193-EFA3A869-8632-4DEA-A64E-89B4ADC83778Q41680713-9C7857F7-C093-473F-BB29-6807E5C88B3FQ41977811-2233A2E5-5CF6-4B4A-9C6A-DB246481A969Q43771862-D5BC9998-DD04-4CAA-86EF-4FFB52EDC74FQ44966073-6D788ADA-7CDE-4CE8-9DEE-17387782D7C0
P2860
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@ast
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@en
type
label
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@ast
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@en
prefLabel
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@ast
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@en
P2093
P356
P1476
Healthcare systems and end-sta ...... ent/funding of ESRD therapies.
@en
P2093
De Vecchi AF
Wiedemann ME
P356
10.1093/NDT/14.SUPPL_6.31
P407
P478
14 Suppl 6
P577
1999-01-01T00:00:00Z